Company Performance Metrics
- Johan Thissen: CFO & Risk
- Miguel Boekhold: CTO
Neolook Solutions B.V. is a Netherlands-based MedTech company founded in 2020 as an independent spin-out from Royal Philips, with roots in a 2016-2017 clinical proof-of-concept at Fatebenefratelli Hospital in Rome. The company specialises in medical-grade livestream and datastream applications for neonatal (NICU) and paediatric intensive care
(PICU), serving three core stakeholder groups: families, clinical practitioners, and researchers. The S2S Platform - comprising S2S Family, S2S Professional, and S2S Academic - enables secure high-resolution video and data connectivity across the full care continuum, from bedside to home. The EarlyMoves product line adds AI-ready remote General Movement Assessment for early detection of neurological disorders in high-risk infants. Neolook has achieved CE MDR Class I certification, ISO 27001, and NEN 7510 compliance. The company has been designated a national NICU facility in the Netherlands at the request of Dutch health insurers, validating significant institutional demand.